QuidelOrtho to Report Second Quarter 2026 Financial Results
Rhea-AI Summary
QuidelOrtho (Nasdaq: QDEL) announced it will report financial results for its second quarter 2026, ended June 28, 2026, after the market close on Thursday, August 6, 2026. A conference call to discuss the results will begin at 2:00 p.m. PT / 5:00 p.m. ET, accessible via the Events & Presentations section of the Investor Relations page on the company’s website. Presentation materials and a replay of the call will also be made available in the same section.
Positive
- None.
Negative
- None.
Market reaction after 2Q26 earnings report: QDEL -3.20% in the Jul 24 session
In the Jul 24 session, QDEL declined 3.20%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 21 | earnings date notice | Neutral | -10.1% | Prior earnings-date announcement preceded a 10.11% negative 24-hour price reaction. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
The one tag-matched historical earnings-date event was followed by a -10.11% 24-hour move.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Following the release of financial results, QuidelOrtho will hold a conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can access the call from the "Events & Presentations" section of the "Investor Relations" page of the Company's website at https://ir.quidelortho.com. Presentation materials will also be posted to the "Events & Presentations" section of the "Investor Relations" page of the Company's website at the time of the call. A replay of the conference call will be available shortly after the event on the "Investor Relations" page of the Company's website under the "Events & Presentations" section.
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@QuidelOrtho.com
Media Contact:
Stephanie Kleewein
Senior Corporate Communications and PR Manager
media@QuidelOrtho.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-to-report-second-quarter-2026-financial-results-302833933.html
SOURCE QuidelOrtho Corporation